Battling the <scp>HIV</scp>/<scp>AIDS</scp> Epidemic: Triumphs and Barriers

McColl, Eliza R.; Kojovic, Dea; Piquette-Miller, Micheline

doi:10.1002/cpt.1202

Cited by 3 publications

(3 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Waitt et al (2018) show that mother-to-child transmission in women with a viral load reduced by therapy allows non-transmission to the child. The results of this study have also been confirmed as regards the infection between serum-discordant couples, also indicating the time necessary before zeroing the viral load of the subject affected by HIV (Bavinton et al, 2018;Safier & Sauer, 2017;Woodson, 2018;McColl, Kojovic, & Piquette-Miller, 2018). The communication of this element linked to the treatment and elimination of the possible transmission between serum-discordant individuals in antiretroviral therapy thus becomes an essential element in communication towards the citizens.…”

Section: Hiv People Under Therapysupporting

confidence: 69%

A Community-Based Social Marketing Strategy to Prevent HIV and Fight Stigma

Brescia¹,

Caratù²,

Scaioli³

2019

IJBM

View full text Add to dashboard Cite

There is evidence that Public Service Announcements are a crucial tool in reducing stigma and call for people to overtly seek help for their illnesses (Corrigan, Powell, Al-Khouja, 2015). In this frame, the study analyses the elements that must be present in a campaign to prevent HIV and the stigma of HIV + people, in order to redefine the essential elements in the search for effectiveness and efficiency. This campaign created for the city of Turin (Italy) represents a useful example to analyse the different phases and desired outcomes of a communication campaign. To our knowledge, this is the first European study to use data collected during a community-based activity on HIV / AIDS testing in order to build an effective communication campaign. The analysis was conducted on both quantitative and qualitative aspects of the campaign. To conduct the analysis, the literature on social marketing is analyzed in association with epidemiological and economic elements. A campaign based on community-based elements with the involvement of non-profit organizations leads to positive and innovative effects both in terms of communication and realization and relapses according to the process defined by the social marketing strategy. The statistical analysis shows a relationship between those who take the rapid test at the non-profit organization and the HIV test for the first time, demonstrating the effectiveness of the prevention campaign in the population that does not belong to the health system.

show abstract

Section: Hiv People Under Therapysupporting

confidence: 69%

A Community-Based Social Marketing Strategy to Prevent HIV and Fight Stigma

Brescia¹,

Caratù²,

Scaioli³

2019

IJBM

View full text Add to dashboard Cite

show abstract

“…Additionally, over half of the approved antivirals are used to treat HIV. After the approval of the first antiviral for HIV in 1987, AIDS-related deaths have decreased by about 60%-80% (Andrei, 2021;McColl et al, 2018). However, AIDS still accounts for one million deaths annually.…”

Section: Antiviral Drugsmentioning

confidence: 99%

Antiviral nanopharmaceuticals: Engineered surface interactions and virus‐selective activity

Kolanthai

Neal

Kumar

et al. 2022

WIREs Nanomed Nanobiotechnol

View full text Add to dashboard Cite

The COVID‐19 pandemic has inspired large research investments from the global scientific community in the study of viral properties and antiviral technologies (e.g., self‐cleaning surfaces, virucides, antiviral drugs, and vaccines). Emerging viruses are a constant threat due to the substantial variation in viral structures, limiting the potential for expanded broad‐spectrum antiviral agent development, and the complexity of targeting multiple and diverse viral species with unique characteristics involving their virulence. Multiple, more infectious variants of SARS‐CoV2 (e.g., Delta, Omicron) have already appeared, necessitating research into versatile, robust control strategies in response to the looming threat of future viruses. Nanotechnology and nanomaterials have played a vital role in addressing current viral threats, from mRNA‐based vaccines to nanoparticle‐based drugs and nanotechnology enhanced disinfection methods. Rapid progress in the field has prompted a review of the current literature primarily focused on nanotechnology‐based virucides and antivirals. In this review, a brief description of antiviral drugs is provided first as background with most of the discussion focused on key design considerations for high‐efficacy antiviral nanomaterials (e.g., nanopharmaceuticals) as determined from published studies as well as related modes of biological activity. Insights into potential future research directions are also provided with a section devoted specifically to the SARS‐CoV2 virus. This article is categorized under: Toxicology and Regulatory Issues in Nanomediciney > Toxicology of Nanomaterials Therapeutic Approaches and Drug Discovery > Nanomedicine for Infectious Disease Therapeutic Approaches and Drug Discovery > Nanomedicine for Respiratory Disease

show abstract

“…The development of effective HIV treatments was remarkable in speed and success, boosting antiviral research. After the approval of the first antiretroviral drug in 1987, a breakthrough in HIV therapy was the introduction in mid-1990's of HAART able to reduce AIDSrelated deaths by 60-80% (30). Although tremendous efforts have been done in antiretroviral therapy, culminating in the one-pill once-a-day regimens, there are still about one million people dying of AIDS per year.…”

Section: Antivirals: Successful Stories and Future Stepsmentioning

confidence: 99%

Vaccines and Antivirals: Grand Challenges and Great Opportunities

Andreï

2021

Front.Virol.

View full text Add to dashboard Cite

Battling the HIV/AIDS Epidemic: Triumphs and Barriers

Cited by 3 publications

References 11 publications

A Community-Based Social Marketing Strategy to Prevent HIV and Fight Stigma

A Community-Based Social Marketing Strategy to Prevent HIV and Fight Stigma

Antiviral nanopharmaceuticals: Engineered surface interactions and virus‐selective activity

Vaccines and Antivirals: Grand Challenges and Great Opportunities

Contact Info

Product

Resources

About